Orchestra BioMed Holdings, Inc.OBIONASDAQ
Loading
Year-over-year free cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | 84.50% |
| Q3 2025 | 4.50% |
| Q2 2025 | 6.98% |
| Q1 2025 | -22.60% |
| Q4 2024 | 0.90% |
| Q3 2024 | -33.50% |
| Q2 2024 | 21.41% |
| Q1 2024 | -19.61% |
| Q4 2023 | -6.50% |
| Q3 2023 | 2.05% |
| Q2 2023 | 27.05% |
| Q1 2023 | -63.86% |
| Q4 2022 | -85.42% |
| Q3 2022 | 49.28% |
| Q2 2022 | -74.18% |
| Q1 2022 | -13.58% |
| Q4 2021 | 3.11% |
| Q3 2021 | -10.68% |
| Q2 2021 | 22.40% |
| Q1 2021 | 0.00% |